FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...

The Food and Drug Administration is rolling out an aggressive plan to make generative AI a linchpin in its decision-making, ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.

The FDA  plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...

The FDA has started exploring how AI can be used to accelerate drug approvals in collaboration with OpenAI amid oversight ...

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

The FDA is gathering up AI talent. The Food and Drug Administration is bringing on new artificial intelligence talent and ...

OpenAI has reportedly met with officials from the Food and Drug Administration to discuss how AI could speed up drug ...

Jeremy Walsh is now heading up artificial intelligence and information technology in a newly created position at the FDA.

Commissioner Martin Makary also said the agency would roll out a generative AI system across its centers that will help FDA ...

Overview Research & Development Revenue of $6.7 MillionImproved Capital Structure Reflected in Cash of $14.1 MillionContinued work on planned De Novo submission to the FDA in the first half of 2025 ...